CRYSTAL HOBERG: Open Payments
NPI 1225428543 · LONGWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,429 in 145 payments from 39 companies in 2025. Trend: 2023 $5,292 · 2024 $4,581 · 2025 $4,429
Food & beverage: $3,579Consulting: $842Education: $9
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $916 |
| Novartis Pharmaceuticals Corporation | 18 | $334 |
| ADC THERAPEUTICS AMERICA, INC. | 3 | $288 |
| AstraZeneca Pharmaceuticals LP | 12 | $283 |
| Daiichi Sankyo Inc. | 13 | $280 |
| Merck Sharp & Dohme LLC | 9 | $236 |
| E.R. Squibb & Sons, L.L.C. | 5 | $200 |
| Janssen Biotech, Inc. | 10 | $195 |
| ABBVIE INC. | 8 | $175 |
| Geron Corporation | 2 | $159 |
Products named: Enhertu, ZYNLONTA, EPKINLY, KEYTRUDA, RYTELO, KISQALI, Zoladex, Lenvima.
Industry payments across FL — which companies pay providers there.
